Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex
- PMID: 12574258
- PMCID: PMC149684
- DOI: 10.1128/JCM.41.2.627-631.2003
Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex
Abstract
A multicenter study was conducted to assess the interlaboratory reproducibility of susceptibility testing of Mycobacterium avium complex (MAC) by broth microdilution using two different media (cation-adjusted Mueller-Hinton broth with 5% oleic acid-albumin-dextrose-catalase and 7H9 broth with casein) and by macrodilution using the BACTEC 460TB and 12B media at pH 6.8 and 7.3 to 7.4. Ten well-characterized strains of MAC (four macrolide susceptible, six macrolide resistant) were tested against clarithromycin and azithromycin (the latter only by BACTEC 460TB, pH 6.8). At each site, strains were tested against clarithromycin three times on each of three separate days (nine testing events per isolate) by using a common lot of microdilution trays and BACTEC 12B medium, pH 6.8; strains were tested once on three separate days against clarithromycin in 12B medium at pH 7.3 to 7.4 and against azithromycin. Agreement among MICs (i.e., mode +/- 1 twofold dilution) was 100% for all strains and both drugs when BACTEC 460TB was used, regardless of the pH of the medium, but varied when microdilution with either medium was used, particularly with susceptible strains. Agreement based on interpretive category, with NCCLS-recommended breakpoints, was 100% for all strains with the BACTEC 460TB method (both drugs and both pH values) and with microdilution using 7H9 broth. With microdilution and Mueller-Hinton broth, agreement by interpretive category was 100% for eight isolates and >90% for two; errors occurred only in laboratories where personnel had minimal experience with this technique. MAC susceptibility testing may be performed by broth macrodilution or microdilution at either pH, with NCCLS-recommended interpretive breakpoints. However, because visual interpretation of broth microdilution end points is subjective, it is more prone to reader error; therefore, this method requires greater expertise than the BACTEC 460TB. Both techniques require appropriate validation and continued documentation of proficiency.
Similar articles
-
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.J Clin Microbiol. 1999 Jun;37(6):1676-82. doi: 10.1128/JCM.37.6.1676-1682.1999. J Clin Microbiol. 1999. PMID: 10325306 Free PMC article.
-
Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.J Clin Microbiol. 2000 Feb;38(2):656-61. doi: 10.1128/JCM.38.2.656-661.2000. J Clin Microbiol. 2000. PMID: 10655363 Free PMC article.
-
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH.J Clin Microbiol. 1997 Jun;35(6):1311-5. doi: 10.1128/jcm.35.6.1311-1315.1997. J Clin Microbiol. 1997. PMID: 9163435 Free PMC article.
-
Clarithromycin against Mycobacterium avium complex infections.Tuber Lung Dis. 1996 Feb;77(1):19-26. doi: 10.1016/s0962-8479(96)90070-2. Tuber Lung Dis. 1996. PMID: 8733409 Review.
-
[Laboratory media for the cultivation of tubercle bacillus].Kekkaku. 1998 May;73(5):329-37. Kekkaku. 1998. PMID: 9637817 Review. Japanese.
Cited by
-
Development of a rapid detection method for the macrolide resistance gene in Mycobacterium avium using the amplification refractory mutation system-loop-mediated isothermal amplification method.Microbiol Spectr. 2024 Apr 2;12(4):e0233923. doi: 10.1128/spectrum.02339-23. Epub 2024 Feb 16. Microbiol Spectr. 2024. PMID: 38363108 Free PMC article.
-
Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.PLoS One. 2018 Sep 17;13(9):e0203108. doi: 10.1371/journal.pone.0203108. eCollection 2018. PLoS One. 2018. PMID: 30222736 Free PMC article.
-
Mycobacterium avium Complex Disease.Microbiol Spectr. 2017 Apr;5(2):10.1128/microbiolspec.tnmi7-0045-2017. doi: 10.1128/microbiolspec.TNMI7-0045-2017. Microbiol Spectr. 2017. PMID: 28429679 Free PMC article. Review.
-
Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem?Antibiotics (Basel). 2021 Dec 24;11(1):19. doi: 10.3390/antibiotics11010019. Antibiotics (Basel). 2021. PMID: 35052896 Free PMC article. Review.
-
Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility.J Clin Microbiol. 2019 Mar 28;57(4):e01756-18. doi: 10.1128/JCM.01756-18. Print 2019 Apr. J Clin Microbiol. 2019. PMID: 30760530 Free PMC article.
References
-
- Centers for Disease Control and Prevention. 1999. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Morb. Mortal. Wkly. Rep. 48:1-59. - PubMed
-
- Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, R. Sattler, et al. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. Ann. Intern. Med. 121:905-911. - PubMed
-
- Currier, J. 1996. Progress report: prophylaxis and therapy for MAC. AIDS Clin. Care 8:45-48. - PubMed
-
- Currier, J. S., P. L. Williams, S. L. Koletar, S. E. Cohn, R. L. Murphy, A. E. Heald, R. Hafner, E. L. Bassily, H. M. Lederman, C. Knirsch, C. A. Benson, H. Valdez, J. A. Aberg, J. A. McCutchan, et al. 2000. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 133:493-503. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical